Search results
Results From The WOW.Com Content Network
GlaxoSmithKline Pharmaceuticals Ltd is an Indian research-based pharmaceutical and healthcare company, and a subsidiary of GSK. [ 4][ 5] The company's product portfolio includes prescription medicines and vaccines. Its prescription medicines range across therapeutic areas such as anti-infectives, dermatology, gynaecology, diabetes, oncology ...
Rotarix (human rotavirus vaccine, live attenuated) Shingrix (for Zoster Vaccine Recombinant, Adjuvanted) Synflorix (pneumococcal polysaccharide conjugate vaccine (adsorbed)) Twinrix (for combined hepatitis A (inactivated virus) and hepatitis B vaccine (genetically derived surface antigen)) Typherix (typhoid vaccine (purified polysaccharide ...
GSK plc (an acronym from its former name GlaxoSmithKline plc) is a British multinational pharmaceutical and biotechnology company with global headquarters in London. [3] [4] It was established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, [n 1] which was itself a merger of a number of pharmaceutical companies around the Smith, Kline & French firm.
GlaxoSmithKline (NYS: GSK) announced today that it plans to raise its stakes in GlaxoSmithKline Consumer Nigeria and India-based GlaxoSmithKline Consumer Healthcare. The pharmaceutical's ownership ...
Largest selling pharmaceutical products of 2015. Drugs with sales above $5 billion in 2015 included: [3] [4] ... GlaxoSmithKline: 5,227 (778) 12 Rosuvastatin: Crestor
Haleon plc is a British multinational consumer healthcare company with headquarters in Weybridge, England. [ 3] It is one of the largest consumer healthcare businesses in the world, with brands including Sensodyne toothpaste, Panadol and Advil painkillers and Centrum vitamins. [ 4] The company was projected to be a global leader in over the ...
June 26, 2024 at 7:57 AM. (Reuters) -Haleon will sell its nicotine replacement therapy business outside the U.S. to a unit of India's Dr. Reddy's for 500 million pounds ($632.55 million), the ...
In 2010, Horlicks accounted for 85% of the ₹ 23.06 billion (US$280 million) revenue of GlaxoSmithKline in India. [15] In 2012 it was the most widely consumed packaged beverage in India, after bottled water .